ACHV
NASDAQ · Biotechnology
Achieve Life Sciences Inc
$6.32
+0.03 (+0.48%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+404.6% upside
Low Target
$22.93
Average Target
$31.89
High Target
$41.27
Current Price
$6.32
Current
$6.32
$6.32
Target
$31.89
$31.89
$22.93
$31.89 avg
$41.27
Scenario Analysis
Bear Case
$22.93
262.8%
Low target
Base Case
$31.89
+404.6%
Avg target
Bull Case
$41.27
+553.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$8.64
-26.9% from high
52-Week Low
$2.62
+141.2% from low
Target vs 52W High
$31.89
+269.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.2% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.1% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -17.6% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -30.6% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -50.5% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -31.6% |